Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
12/2007
12/05/2007CN101081239A Lucidum glycopeptide and method for their production
12/05/2007CN101081234A Method for preparation of claybank propolis soft capsules
12/05/2007CN101081230A Poly(potassium and sodium styrene sulfonate) its manufacture and its uses
12/05/2007CN101081227A Composition of diammonium glycyrrhizinate
12/05/2007CN101081221A Use of dihydro myricetin in the preparing of medicine
12/05/2007CN101081213A Butane diacid(5-androstene-17-ketone- 3beta -hydroxyl group ) diester solid dispersoid and method for making same and applications thereof
12/05/2007CN101081092A beverage for expelling toxin and treating melancholy
12/05/2007CN101081091A Vision-improving and intelligent-improving beverage
12/05/2007CN101081090A Plantain beverage for protecting liver
12/05/2007CN101081079A Ginseng and astragalus conjee for improving digestion
12/05/2007CN101081074A Selenium germanium peptide jujube tea paste for effecting radical cure of alimentary tract disease
12/05/2007CN101081073A Selenium germanium peptide jujube tea paste for effecting radical cure of hepatitis B
12/05/2007CN101081054A Amber aroma health-care tea
12/05/2007CN100352923C Nucleic acids, polypeptides, and methods for modulating apoptosis
12/05/2007CN100352921C Compositions and methods for identifying antigens which elicit an immune response
12/05/2007CN100352915C Bacillus subtilis, composite preparation, and method for preparing the composite preparation
12/05/2007CN100352908C Liver-nourishing and antilipemic wine and production thereof
12/05/2007CN100352819C Novel compounds as NS3-serine protease inhibitors of hepatitis c virus
12/05/2007CN100352807C Chemical compounds
12/05/2007CN100352806C 4-piperidinyl alkylamine derivatives as muscarinic receptor antagonists
12/05/2007CN100352804C 酰胺衍生物 Amide derivatives
12/05/2007CN100352481C Tonify product
12/05/2007CN100352476C Weichangyanping capsule for treating gastroenteritis
12/05/2007CN100352468C Yinzhihuang tablet of oriental wormwood, cape jasmine and baicalin, and its preparing and detecting method
12/05/2007CN100352454C Chinese medicine preparation with invigorating kidney function
12/05/2007CN100352443C Pharmaceutical nanoparticulate composition of a tachykinin receptor antagonist
12/05/2007CN100352437C Piperazine derivatives, their preparation and their use for treating central nervous system (CNS) disorders
12/05/2007CN100352436C Oral suspension of tegaserod
12/05/2007CN100352433C Fatty alcohols and fatty acid esters useful for treatment of inflammation
12/05/2007CN100352429C Chinese medicine soft capsule for treating hepatitis B and its preparation method
12/05/2007CN100352358C Method for preparing liver-benefiting, face-beautifying milk liquid with micron pine pollen, pearl powder for women
12/05/2007CN100352357C Method for preparing liver-benefiting, face-beautifying milk sheet with micron pine pollen, pearl powder for women
12/05/2007CN100352356C Method for preparing liver-benefiting, face-beautifying soybean soybean milk sheet with micron pine pollen, pearl powder for women
12/04/2007US7304144 Antibodies binding to human TSLP Polypeptides
12/04/2007US7304090 Using fluorescein; polycystic kidney disease, diarrhea, antiarrhythmia agents, antitumor agents, contraceptice
12/04/2007US7304072 Spiro compounds
12/04/2007US7304066 Pyridyl cyanoguanidine compounds
12/04/2007US7304064 1-[(indol-3-yl)carbonyl]piperazine derivatives
12/04/2007US7304059 Substituted quinazolin-4-ylamine analogues
12/04/2007US7304052 Irritable bowel syndrome; gastrointestinal disorders
12/04/2007US7304051 Quinoxaline compounds
12/04/2007US7304033 Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules
12/04/2007US7303895 Choline transport like (CTL) membrane proteins involved in choline transport
12/04/2007US7303889 Ligand for G-protein coupled receptor GPR43 and uses thereof
12/04/2007CA2445744C Antiviral nucleoside derivatives
12/04/2007CA2346555C Method and device for preparing a dental implant by immersion in a mesenchymal cell culture
12/04/2007CA2345622C Tricyclic .delta.3-piperidines as .alpha.2-antagonists
12/04/2007CA2262647C Methods for regulating gastrointestinal motility
12/04/2007CA2255891C Compositions and methods for treating or preventing diseases of body passageways
12/04/2007CA2212205C Use of xanthine derivatives for the modulation of apoptosis
11/2007
11/30/2007CA2591352A1 Treatment for herpes simplex virus and other infectious diseases
11/29/2007WO2007136719A2 Biotherapeutic compositions comprising probiotic escherichia coli and uses thereof
11/29/2007WO2007136326A2 ) t e text as een esta s e y t s ut o ty to rea as o ows: 1- [ (4- [benzoyl (methyl) amino] -3- (phenyl) butyl] azetidine derivatives for the treatment of gastrointestinal disorders 3
11/29/2007WO2007136325A1 1- [ (4- [benzoyl (methyl) amino] -3- (phenyl) butyl] azetidine derivatives for the treatment of gastrointestinal disorders 2
11/29/2007WO2007136324A1 1- [ (4- [benzoyl (methyl) amino] -3- (phenyl) butyl] azetidine derivatives for the treatment of gastrointestinal disorders 1
11/29/2007WO2007136103A1 Antitumor agent for thyroid cancer
11/29/2007WO2007135390A1 Prevention of plaque formation
11/29/2007WO2007134867A2 Treating muscular disorders and improving muscular function
11/29/2007WO2007109547A3 Method of preventing and treating hepatic disease using a2b adenosine receptor antagonists
11/29/2007WO2007090087A3 Use of corticotropin releasing factor receptor-2 inhibitors for treating insulin-related diseases
11/29/2007WO2007051463A3 Use of an activated zeolite as a pharmaceutical agent for reducing poisonous substances
11/29/2007US20070276138 Modulators of peroxisome proliferator activated receptors
11/29/2007US20070276046 Alpha-Aminoamide Derivatives Useful as Anti-Inflammatory Agents
11/29/2007US20070276039 Pharmaceutical uses for alpha2delta ligands
11/29/2007US20070276016 Cholecystokinin (CCK2) receptor modulators; e.g. 2-(Benzo[1,2,5]thiadiazole-4sulfonylamino)-4-fluoro-N-[1-(4-fluoro-phenyl)-ethyl]-N-methyl-benzamide; pancreatic adenocarcinoma, pain, eating disorders, gastro-esophageal reflux disease, ulcers, anxiety
11/29/2007US20070276008 Pharmaceutical formulation comprising glycine as a stabilizer
11/29/2007US20070276007 Administration of pharmaceuticals
11/29/2007US20070276001 Biphenyl-pyrazolecarboxamide compounds
11/29/2007US20070275993 Combinations Of An Anti Emetic Agent And An Enkephalinase Inhibitor
11/29/2007US20070275973 Aryl fused azapolycyclic compounds
11/29/2007US20070275968 Substituted Biphenyl Derivative
11/29/2007US20070275954 Novel Fused Heterocycles and Uses Thereof
11/29/2007US20070275950 2-Phenylpyridine Derivative
11/29/2007US20070275912 Nucleoside derivatives as inhibitors of rna-dependent RNA viral polymerase
11/29/2007US20070275095 Treatment of inflammatory, autoimmune, or other disorders, using agents that reduce the sequestering of zinc by calprotectin
11/29/2007US20070275051 Pharmaceutical formulations: salts of 8-[{1-(3,5-Bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the same
11/29/2007US20070275021 New cosmetic, personal care, cleaning agent, and nutritional supplement compositions and methods of making and using same
11/29/2007US20070274993 Immunocompetent Cell Activation Inhibitor and Use Thereof
11/29/2007US20070274974 Compositions and methods for restoring immune responsiveness in patients with immunological defects
11/29/2007US20070274955 Novel Galactooligosaccharide Composition and the Preparation Thereof
11/29/2007US20070274930 Particulate Flavoring Composition
11/29/2007CA2652559A1 Biotherapeutic compositions and uses thereof
11/29/2007CA2652443A1 1- [ (4- [benzoyl (methyl) amino] -3- (phenyl) butyl] azetidine derivatives for the treatment of gastrointestinal disorders 1
11/29/2007CA2652442A1 Antitumor agent for thyroid cancer
11/29/2007CA2651153A1 Antidiabetic bicyclic compounds
11/28/2007EP1858881A1 Process for the preparation of optically active derivatives of 2-(2-pyridylmethylsulfinyl)-benzimidazole via inclusion complex with 1,1'-binaphthalene-2, 2'diol
11/28/2007EP1858872A1 Derivatives of n-[(4,5-diphenyl-3-alkyl-2-thienyl) methyl] amine (amide, thiourea and urea) as cannabinoid cb1 receptor antagonists
11/28/2007EP1858519A2 Orally used compatible solute containing agents
11/28/2007EP1737862A4 Imidazopyridine compound
11/28/2007EP1406613B1 Organic nitratederivatives for the treatment of atherosclerosis and vascular diseases
11/28/2007EP1373257B1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
11/28/2007EP1328245B1 Dental care compositions
11/28/2007EP1315718B1 Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof
11/28/2007EP1293507B1 Process for producing crystal
11/28/2007EP0991666B1 Alpha 1-antitrypsin preparation and method for the production thereof
11/28/2007CN101080404A Pyrimidinylisoxazol derivative
11/28/2007CN101080250A Methods of using fatty-acid esters of estrogens and thermogenic compounds for reducing the body weight of a mammal and compositions containing the same
11/28/2007CN101078012A 干细胞分化 Stem cell differentiation
11/28/2007CN101077883A Small interference RNA sequence of hepatitis B virus gene and preparation method thereof
11/28/2007CN101077412A Method for treating chronic colitis
1 ... 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 ... 1258